UBS on Bristol-Myers Squibb's (BMY) INX-189 Stumble: At Best Puts Bristol Behind; At Worst, Out of the Race
Tweet Send to a Friend
UBS maintains a 'Neutral' on Bristol-Myers Squibb Co. (NYSE: BMY) price target of $34.00 (from $36.00).
Analyst, Marc Goodman ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Marc Goodman ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
